Discordant	O
Haplotype	O
Sequencing	O
Identifies	O
Functional	O
Variants	O
at	O
the	O
2q33	O
Breast	O
Cancer	O
Risk	O
Locus	O
.	O


The	O
findings	O
from	O
genome	O
-	O
wide	O
association	O
studies	O
hold	O
enormous	O
potential	O
for	O
novel	O
insight	O
into	O
disease	O
mechanisms	O
.	O


A	O
major	O
challenge	O
in	O
the	O
field	O
is	O
to	O
map	O
these	O
low	O
-	O
risk	O
association	O
signals	O
to	O
their	O
underlying	O
functional	O
sequence	O
variants	O
(	O
FSV	O
)	O
.	O


Simple	O
sequence	O
study	O
designs	O
are	O
insufficient	O
,	O
as	O
the	O
vast	O
numbers	O
of	O
statistically	O
comparable	O
variants	O
and	O
a	O
limited	O
knowledge	O
of	O
noncoding	O
regulatory	O
elements	O
complicate	O
prioritization	O
.	O


Furthermore	O
,	O
large	O
sample	O
sizes	O
are	O
typically	O
required	O
for	O
adequate	O
power	O
to	O
identify	O
the	O
initial	O
association	O
signals	O
.	O


One	O
important	O
question	O
is	O
whether	O
similar	O
sample	O
sizes	O
need	O
to	O
be	O
sequenced	O
to	O
identify	O
the	O
FSVs	O
.	O


Here	O
,	O
we	O
present	O
a	O
proof	O
-	O
of	O
-	O
principle	O
example	O
of	O
an	O
extreme	O
discordant	O
design	O
to	O
map	O
FSVs	O
within	O
the	O
2q33	O
low	O
-	O
risk	O
breast	O
cancer	O
locus	O
.	O


Our	O
approach	O
employed	O
DNA	O
sequencing	O
of	O
a	O
small	O
number	O
of	O
discordant	O
haplotypes	O
to	O
efficiently	O
identify	O
candidate	O
FSVs	O
.	O


Our	O
results	O
were	O
consistent	O
with	O
those	O
from	O
a	O
2	O
,	O
000	O
-	O
fold	O
larger	O
,	O
traditional	O
imputation	O
-	O
based	O
fine	O
-	O
mapping	O
study	O
.	O


To	O
prioritize	O
further	O
,	O
we	O
used	O
expression	O
-	O
quantitative	O
trait	O
locus	O
analysis	O
of	O
RNA	O
sequencing	O
from	O
breast	O
tissues	O
,	O
gene	O
regulation	O
annotations	O
from	O
the	O
ENCODE	O
consortium	O
,	O
and	O
functional	O
assays	O
for	O
differential	O
enhancer	O
activities	O
.	O


Notably	O
,	O
we	O
implicate	O
three	O
regulatory	O
variants	O
at	O
2q33	O
that	O
target	O
CASP8	S-GENE
(	O
rs3769823	O
,	O
rs3769821	O
in	O
CASP8	S-GENE
,	O
and	O
rs10197246	O
in	O
ALS2CR12	S-GENE
)	O
as	O
functionally	O
relevant	O
.	O


We	O
conclude	O
that	O
nested	O
discordant	O
haplotype	O
sequencing	O
is	O
a	O
promising	O
approach	O
to	O
aid	O
mapping	O
of	O
low	O
-	O
risk	O
association	O
loci	O
.	O


The	O
ability	O
to	O
include	O
more	O
efficient	O
sequencing	O
designs	O
into	O
mapping	O
efforts	O
presents	O
an	O
opportunity	O
for	O
the	O
field	O
to	O
capitalize	O
on	O
the	O
potential	O
of	O
association	O
loci	O
and	O
accelerate	O
translation	O
of	O
association	O
signals	O
to	O
their	O
underlying	O
FSVs	O
.	O


Cancer	O
Res	O
;	O
76	O
(	O
7	O
)	O
;	O
1916	O
-	O
25	O
.	O


2016	O
AACR	O
.	O
